Evidence map›Paper›PMID 41089270›Full record

ArticleFrontiers in digital health2025

Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions.

Emilia Daghir-Wojtkowiak, Javier Alfaro, Michele Mastromattei, Aleksander Palkowski, Mark Stares, Ana Roca-Umbert, Andraz Krajnc, Riccardo Leoni, Anne Boland, Aria Nourbaksh and 85 more

Abstract read
In one paragraph

Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Multimodal Wearable Biosensing Meets Multidomain AI: A Pathway to Decentralized Healthcare.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

95 authors.

Emilia Daghir-Wojtkowiak *International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland.
Javier Alfaro *International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland.
Michele MastromatteiUniversity of Rome "Tor Vergata", Rome, Italy.
Aleksander PalkowskiInternational Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland.
Mark StaresUrology Department, Western General Hospital, NHS Lothian, Edinburgh, United Kingdom.
Ana Roca-UmbertPredictBy Research and Consulting SLU, Barcelona, Spain.
Andraz KrajncCaretronic d.o.o. Kranj, Slovenia.
Riccardo LeoniDSTECH S.r.l., Rome, Italy.
Anne BolandCEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, Evry, France.
Aria NourbakshUniversity of Rome "Tor Vergata", Rome, Italy.
Ashwin KallorInternational Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland.
Camille DuckiCentre Hospitalier Universitaire de Grenoble (CHU), Grenoble, France.
Davide VendittiUniversity of Rome "Tor Vergata", Rome, Italy.
Carla MontesanoUniversity of Rome "Tor Vergata", Rome, Italy.
Chiara CiprianiUniversity of Rome "Tor Vergata", Rome, Italy.
Daniel FariaLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Delphine PfliegerIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Elisa ZagoPersonal Genomics Srl, Verona, Italy.
Etienne BardetIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Filipa SerranoLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Florian JeanneretIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Damien AlougesIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Liangwei YinIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Elodine CoqueletIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Apolline BacquetIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Francesco BonchiEurecat, Centre Tecnològic de Catalunya, Barcelona, Spain.
Francesco MaiorinoUniversity of Rome "Tor Vergata", Rome, Italy.
Francesco TorinoUniversity of Rome "Tor Vergata", Rome, Italy.
Georges BedranInternational Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland.
Jean-Alexandre LongCentre Hospitalier Universitaire de Grenoble (CHU), Grenoble, France.
Laura BalbiLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Laurent GuyonIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Liana BevilacquaFondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Manuel FiorelliUniversity of Rome "Tor Vergata", Rome, Italy.
Marie-Catherine WagnerDepartment of Innovation and Digitalisation in Law, University of Vienna, Vienna, Austria.
Mario ReyesEurecat, Centre Tecnològic de Catalunya, Barcelona, Spain.
Mario RoselliUniversity of Rome "Tor Vergata", Rome, Italy.
Marta Contreiras SilvaLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Michal WaleronInternational Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland.
Nikolas DovrolisLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Odile Filhol-CochetIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
In Hwa UmSchool of Medicine, University of St Andrews, St Andrews, United Kingdom.
Georg WolfleinSchool of Medicine, University of St Andrews, St Andrews, United Kingdom.
Patrícia EugénioLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Pauline BazelleIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Pavlos GolnasHealth Policy Institute (HPI), Maroussi, Greece.
Peter ThorpeCaretronic d.o.o. Kranj, Slovenia.
Pierluigi BoveUniversity of Rome "Tor Vergata", Rome, Italy.
Piyush BoroleSchool of Informatics, University of Edinburgh, Edinburgh, United Kingdom.
Roberta BernardiniUniversity of Rome "Tor Vergata", Rome, Italy.
Rohit KumarEurecat, Centre Tecnològic de Catalunya, Barcelona, Spain.
Rosella CicconiUniversity of Rome "Tor Vergata", Rome, Italy.
Saskia KaltenbrunnerDepartment of Innovation and Digitalisation in Law, University of Vienna, Vienna, Austria.
Saverio GravinaDSTECH S.r.l., Rome, Italy.
Simona BrezarCaretronic d.o.o. Kranj, Slovenia.
Stefan SymeonidesUrology Department, Western General Hospital, NHS Lothian, Edinburgh, United Kingdom.
Steven McGinnCEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, Evry, France.
Susana NunesLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Ted HuppInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.
Yuri GordienkoNational Technical University of Ukraine Igor Sikorsky Kyiv Polytechnic Institute, Kyiv, Ukraine.
Dimitrios VarvarasHealth Policy Institute (HPI), Maroussi, Greece.
Sergii StirenkoNational Technical University of Ukraine Igor Sikorsky Kyiv Polytechnic Institute, Kyiv, Ukraine.
Luciano XumerlePersonal Genomics Srl, Verona, Italy.
Stefania MarianiPersonal Genomics Srl, Verona, Italy.
Assilah BouzitCentre Hospitalier Universitaire de Grenoble (CHU), Grenoble, France.
Stéphane GazutLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Heiko PothEURICE, Heinrich-Hertz-Allee 1, St. Ingbert, Germany.
Kyriakos SouliotisHealth Policy Institute (HPI), Maroussi, Greece.
Hector KatifelisLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Elena VerzoniFondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Giuseppe ProcopioFondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Sarah SchochDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Francisco Lupiáñez-VillanuevaPredictBy Research and Consulting SLU, Barcelona, Spain.
Sandra TürkEURICE, Heinrich-Hertz-Allee 1, St. Ingbert, Germany.
Katarzyna BarudDepartment of Innovation and Digitalisation in Law, University of Vienna, Vienna, Austria.
Dimitri KorolioukNational Technical University of Ukraine Igor Sikorsky Kyiv Polytechnic Institute, Kyiv, Ukraine.
Juan CaubetEurecat, Centre Tecnològic de Catalunya, Barcelona, Spain.
Yamir MorenoInstitute for Biocomputation and Physics of Complex Systems and Department of Theoretical Physics, University of Zaragoza, Zaragoza, Spain.
Jean-Luc DescotesCentre Hospitalier Universitaire de Grenoble (CHU), Grenoble, France.
Christina GolnaHealth Policy Institute (HPI), Maroussi, Greece.
Valentina GuadalupiFondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Paolo GaragnaniPersonal Genomics Srl, Verona, Italy.
Maria GazouliLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Jean-François DeleuzeCEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, Evry, France.
Frans FolkvordPredictBy Research and Consulting SLU, Barcelona, Spain.
Nikolaus ForgóDepartment of Innovation and Digitalisation in Law, University of Vienna, Vienna, Austria.
David J HarrisonSchool of Medicine, University of St Andrews, St Andrews, United Kingdom.
Håkan AxelsonDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Armando StellatoUniversity of Rome "Tor Vergata", Rome, Italy.
Maurizio MatteiUniversity of Rome "Tor Vergata", Rome, Italy.
Ajitha RajanSchool of Informatics, University of Edinburgh, Edinburgh, United Kingdom.
Alexander LairdUrology Department, Western General Hospital, NHS Lothian, Edinburgh, United Kingdom.
Christophe BattailIRIG, Laboratoire Biosciences et Bioingénierie Pour la Santé, UA2 INSERM-CEA-UGA, Université Grenoble Alpes, Grenoble, France.
Catia PesquitaLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Fabio Massimo ZanzottoUniversity of Rome "Tor Vergata", Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrating multi-modal patient data to support personalized medicine has gained a lot of interest across different health domains over the past decade. Addressing this challenge requires the development and implementation of an informed, evidence-based AI-driven decision-support system continuously maintained and updated to align with the latest clinical guidelines. A key challenge to ensure its real-life adoption lies in translating the outcomes of complex AI-driven data integration and modeling into a form easily understood by the clinical audience. To ensure explainability, knowledge graphs have emerged as data models integrating multi-omics data sources and representing them as interconnected networks. Knowledge graphs offer a framework which AI models can progressively refine, highlighting the most influential features and relationships facilitating transparency of complex interactions and interdependencies. In this perspective we present major components and challenges upon developing a knowledge-based explainable AI system. Additionally, we showcase a current effort undertaken by the Knowledge at the Tips of your Fingers (KATY) consortium to develop the infrastructure for an explainable system supporting best treatment decision for a renal cancer patient.

Indexed as

AIclinical decision-makingexplainabilityfoundation modelsknowledge graphspersonalized cancer treatment

Identifiers

PMID41089270
PMCPMC12515877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.